|
1
|
Pui CH, Relling MV and Downing JR: Acute
lymphoblastic leukemia. N Engl J Med. 350:1535–1548. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
De Keersmaecker K, Marynen P and Cools J:
Genetic insights in the pathogenesis of T-cell acute lymphoblastic
leukemia. Haematologica. 90:1116–1127. 2005.
|
|
3
|
Weng AP, Ferrando AA, Lee W, et al:
Activating mutations of NOTCH1 in human T cell acute lymphoblastic
leukemia. Science. 306:269–271. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhu YM, Zhao WL, Fu JF, et al: NOTCH1
mutations in T-cell acute lymphoblastic leukemia: prognostic
significance and implication in multifactorial leukemogenesis. Clin
Cancer Res. 12:3043–3049. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Allman D, Punt JA, Izon DJ, Aster JC and
Pear WS: An invitation to T and more: notch signaling in
lymphopoiesis. Cell. 109:S1–S11. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Radtke F, Fasnacht N and MacDonald HR:
Notch signaling in the immune system. Immunity. 32:14–27. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liang R, Huang GS, Wang Z, et al: Effects
of human bone marrow stromal cell line (HFCL) on the proliferation,
differentiation and apoptosis of acute myeloid leukemia cell lines
U937, HL-60 and HL-60/VCR. Int J Hematol. 87:152–166. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nefedova Y, Landowski TH and Dalton WS:
Bone marrow stromal-derived soluble factors and direct cell contact
contribute to de novo drug resistance of myeloma cells by distinct
mechanisms. Leukemia. 17:1175–1182. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nefedova Y, Cheng P, Alsina M, Dalton WS
and Gabrilovic DI: Involvement of Notch-1 signaling in bone marrow
stroma-mediated de novo drug resistance of myeloma and other
malignant lymphoid cell lines. Blood. 103:3503–3510. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Carlesso N, Aster JC, Sklar J and Scadden
DT: Notch1-induced delay of human hematopoietic progenitor cell
differentiation is associated with altered cell cycle kinetics.
Blood. 93:838–848. 1999.
|
|
11
|
Sade H, Krishna S and Sarin A: The
anti-apoptotic effect of Notch-1 requires p56lck-dependent,
Akt/PKB-mediated signaling in T cells. J Biol Chem. 279:2937–2944.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rutz S, Mordmüller B, Sakano S and
Scheffold A: Notch ligands Delta-like1, Delta-like4 and Jagged1
differentially regulate activation of peripheral T helper cells.
Eur J Immunol. 35:2443–2451. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Friedenstein AJ, Petrakova KV, Kurolesova
AI and Frolova GP: Heterotopic of bone marrow. Analysis of
precursor cells for osteogenic and hematopoietic tissues.
Transplantation. 6:230–247. 1968.PubMed/NCBI
|
|
14
|
Rebelatto CK, Aguiar AM, Moretão MP, et
al: Dissimilar differentiation of mesenchymal stem cells from bone
marrow, umbilical cord blood, and adipose tissue. Exp Biol Med
(Maywood). 233:901–913. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rao MS and Mattson MP: Stem cells and
aging: expanding the possibilities. Mech Ageing Dev. 122:713–734.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Romanov YA, Svintsitskaya VA and Smirnov
VN: Searching for alternative sources of postnatal human
mesenchymal stem cells: candidate MSC-like cells from umbilical
cord. Stem Cells. 21:105–110. 2003.PubMed/NCBI
|
|
17
|
Phinney DG and Prockop DJ: Concise review:
mesenchymal stem/multipotent stromal cells: the state of
transdifferentiation and modes of tissue repair - current views.
Stem Cells. 25:2896–2902. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ball LM, Bernardo ME, Roelofs H, et al:
Cotransplantation of ex vivo expanded mesenchymal stem cells
accelerates lymphocyte recovery and may reduce the risk of graft
failure in haploidentical hematopoietic stem-cell transplantation.
Blood. 110:2764–2767. 2007. View Article : Google Scholar
|
|
19
|
Le Blanc K, Rasmusson I, Sundberg B, et
al: Treatment of severe acute graft-versus-host disease with third
party haploidentical mesenchymal stem cells. Lancet. 363:1439–1441.
2004.PubMed/NCBI
|
|
20
|
Baksh D, Yao R and Tuan RS: Comparison of
proliferative and multilineage differentiation potential of human
mesenchymal stem cells derived from umbilical cord and bone marrow.
Stem Cells. 25:1384–1392. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Scupoli MT, Perbellini O, Krampera M,
Vinante F, Cioffi F and Pizzolo G: Interleukin 7 requirement for
survival of T-cell acute lymphoblastic leukemia and human
thymocytes on bone marrow stroma. Haematologica. 92:264–266. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ning H, Yang F, Jiang M, et al: The
correlation between cotransplantation of mesenchymal stem cells and
higher recurrence rate in hematologic malignancy patients: outcome
of a pilot clinical study. Leukemia. 22:593–599. 2008. View Article : Google Scholar
|
|
23
|
Apelqvist A, Li H, Sommer L, et al: Notch
signalling controls pancreatic cell differentiation. Nature.
400:877–881. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lobov I, Renard R, Papadopoulos N, et al:
Delta-like ligand 4 (Dll4) is induced by VEGF as a negative
regulator of angiogenic sprouting. Proc Natl Acad Sci USA.
104:3219–3224. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Loomes KM, Stevens SA, O’Brien ML, et al:
Dll3 and Notch1 genetic interactions model axial segmental and
craniofacial malformations of human birth defects. Dev Dyn.
236:2943–2951. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ascano JM, Beverly LJ and Capobianco AJ:
The C-terminal PDZ-ligand of JAGGED1 is essential for cellular
transformation. J Biol Chem. 278:8771–8779. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Docheva D, Haasters F and Schieker M:
Mesenchymal stem cells and their cell surface receptors. Curr
Rheumatol Rev. 4:155–160. 2008. View Article : Google Scholar
|
|
28
|
Calvi LM, Adams GB, Weibrecht KW, et al:
Osteoblastic cells regulate the haematopoietic stem cell niche.
Nature. 425:841–846. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liotta F, Angeli R, Cosmi L, et al:
Toll-like receptors 3 and 4 are expressed by human bone
marrow-derived mesenchymal stem cells and can inhibit their T-cell
modulatory activity by impairing Notch signaling. Stem Cells.
26:279–289. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kurpinski K, Lam H, Chu J, et al:
Transforming growth factor-beta and notch signaling mediate stem
cell differentiation into smooth muscle cells. Stem Cells.
28:734–742. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen L: Co-inhibitory molecules of the
B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol.
4:336–347. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chadwick N, Zeef L, Portillo V, et al:
Identification of novel Notch target genes in T cell leukaemia. Mol
Cancer. 8:352009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
van den Brandt J, Wang D and Reichardt HM:
Resistance of single-positive thymocytes to glucocorticoid-induced
apoptosis is mediated by CD28 signaling. Mol Endocrinol.
18:687–695. 2004.PubMed/NCBI
|
|
34
|
Boise LH, Minn AJ, Noel PJ, et al: CD28
costimulation can promote T cell survival by enhancing the
expression of Bcl-XL. Immunity. 3:87–98. 1995. View Article : Google Scholar
|
